BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(31): 7006-7016 [PMID: 27610012 DOI: 10.3748/wjg.v22.i31.7006] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 94] [Article Influence: 19.6] [Reference Citation Analysis]
Number Citing Articles
1 Breher-Esch S, Sahini N, Trincone A, Wallstab C, Borlak J. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Med Genomics 2018;11:111. [PMID: 30547786 DOI: 10.1186/s12920-018-0438-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
2 Guo R, Nair S, Zhang Y, Ren J. Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis. Int J Obes (Lond) 2017;41:1403-12. [PMID: 28559541 DOI: 10.1038/ijo.2017.128] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
3 Nakashita C, Xi L, Inoue Y, Kabura R, Masuda S, Yamano Y, Katoh T. Impact of dietary compositions and patterns on the prevalence of nonalcoholic fatty liver disease in Japanese men: a cross-sectional study. BMC Gastroenterol 2021;21:342. [PMID: 34481454 DOI: 10.1186/s12876-021-01919-x] [Reference Citation Analysis]
4 Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients 2017;9:E387. [PMID: 28420094 DOI: 10.3390/nu9040387] [Cited by in Crossref: 166] [Cited by in F6Publishing: 139] [Article Influence: 41.5] [Reference Citation Analysis]
5 Notarnicola M, Osella AR, Caruso MG, Pesole PL, Lippolis A, Tutino V, Bonfiglio C, De Nunzio V, Scavo MP, Mirizzi A, Franco I, Lippolis T, D'Alessandro R, Refolo MG, Messa C. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. Int J Mol Sci 2021;22:3899. [PMID: 33918878 DOI: 10.3390/ijms22083899] [Reference Citation Analysis]
6 Song D, Yin L, Wang C, Wen X. Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats. BMC Complement Med Ther 2020;20:27. [PMID: 32020874 DOI: 10.1186/s12906-019-2811-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Abenavoli L, Boccuto L. Is possible to detect nonalcoholic fatty liver disease by a new index including single nucleotide polymorphisms (SNPs)? Ann Transl Med 2018;6:366. [PMID: 30370293 DOI: 10.21037/atm.2018.09.20] [Reference Citation Analysis]
8 Abenavoli L, Milanović M, Milić N, Luzza F, Giuffrè AM. Olive oil antioxidants and non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019;13:739-49. [DOI: 10.1080/17474124.2019.1634544] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Harjumäki R, Pridgeon CS, Ingelman-Sundberg M. CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload. Int J Mol Sci 2021;22:8221. [PMID: 34360999 DOI: 10.3390/ijms22158221] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wessels DH, Rosenberg Z. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? World J Hepatol 2021; 13(2): 233-241 [PMID: 33708352 DOI: 10.4254/wjh.v13.i2.233] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int. 2017;37:936-949. [PMID: 28371239 DOI: 10.1111/liv.13435] [Cited by in Crossref: 109] [Cited by in F6Publishing: 97] [Article Influence: 27.3] [Reference Citation Analysis]
12 Mörwald K, Aigner E, Bergsten P, Brunner SM, Forslund A, Kullberg J, Ahlström H, Manell H, Roomp K, Schütz S, Zsoldos F, Renner W, Furthner D, Maruszczak K, Zandanell S, Weghuber D, Mangge H. Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity. Front Endocrinol (Lausanne) 2020;11:340. [PMID: 32625166 DOI: 10.3389/fendo.2020.00340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zheng X, Ren W, Gong L, Long J, Luo R, Wang Y. The Great Chinese Famine Exposure in Early Life and the Risk of Nonalcoholic Fatty Liver Disease in Adult Women. Ann Hepatol 2017;16:901-8. [PMID: 29055916 DOI: 10.5604/01.3001.0010.5281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
14 Zhang S, Gu Y, Bian S, Górska MJ, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Wang Y, Zhang T, Wang X, Sun S, Wang X, Zhou M, Jia Q, Song K, Qi L, Niu K. Dietary patterns and risk of non-alcoholic fatty liver disease in adults: A prospective cohort study. Clin Nutr 2021;40:5373-82. [PMID: 34560608 DOI: 10.1016/j.clnu.2021.08.021] [Reference Citation Analysis]
15 Klisić A, Kavarić N, Abenavoli L, Stanišić V, Spasojević-Kalimanovska V, Kotur-Stevuljević J, Ninić A. Is endocan a novel potential biomarker of liver steatosis and fibrosis? J Med Biochem 2020;39:363-71. [PMID: 33269025 DOI: 10.2478/jomb-2019-0042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Jorgačević B, Vučević D, Vesković M, Mladenović D, Vukićević D, Vukićević RJ, Todorović V, Radosavljević T. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease. Can J Physiol Pharmacol 2019;97:120-9. [PMID: 30673308 DOI: 10.1139/cjpp-2018-0607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
17 Scarpellini E, Fagoonee S, Rinninella E, Rasetti C, Aquila I, Larussa T, Ricci P, Luzza F, Abenavoli L. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. J Clin Med 2020;9:E2488. [PMID: 32756323 DOI: 10.3390/jcm9082488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
18 Sharifi N, Amani R. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. Crit Rev Food Sci Nutr 2019;59:693-703. [PMID: 29035092 DOI: 10.1080/10408398.2017.1389693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Yang JP, Shin JH, Seo SH, Kim SG, Lee SH, Shin EH. Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte. Int J Mol Sci 2018;19:E2563. [PMID: 30158441 DOI: 10.3390/ijms19092563] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
20 Garousi N, Tamizifar B, Pourmasoumi M, Feizi A, Askari G, Clark CCT, Entezari MH. Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial. Arch Physiol Biochem 2021;:1-9. [PMID: 33689525 DOI: 10.1080/13813455.2021.1890128] [Reference Citation Analysis]
21 Colica C, Boccuto L, Abenavoli L. Silymarin: An option to treat non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8437-8438 [PMID: 29309065 DOI: 10.3748/wjg.v23.i47.8437] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
22 Li G, Rios RS, Wang XX, Yu Y, Zheng KI, Huang OY, Tang LJ, Ma HL, Jin Y, Targher G, Byrne CD, Pan XY, Zheng MH. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. Br J Nutr 2021;:1-8. [PMID: 34176541 DOI: 10.1017/S0007114521002415] [Reference Citation Analysis]
23 Xin X, Chen C, Hu YY, Feng Q. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomed Pharmacother 2019;117:109047. [PMID: 31176163 DOI: 10.1016/j.biopha.2019.109047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
24 Kahan S, Cuker A, Kushner RF, Maahs J, Recht M, Wadden T, Willis T, Majumdar S, Ungar D, Cooper D. Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelines. Haemophilia 2017;23:812-20. [DOI: 10.1111/hae.13291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
25 Aliasghari F, Izadi A, Jabbari M, Imani B, Gargari BP, Asjodi F, Ebrahimi S. Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients? J Med Biochem 2018;37:470-5. [PMID: 30584407 DOI: 10.2478/jomb-2018-0006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Sepulveda-Villegas M, Roman S, Rivera-Iñiguez I, Ojeda-Granados C, Gonzalez-Aldaco K, Torres-Reyes LA, Jose-Abrego A, Panduro A. High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. PLoS One 2019;14:e0208926. [PMID: 30608932 DOI: 10.1371/journal.pone.0208926] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
27 Hosseinabadi S, Rafraf M, Asghari S, Asghari-Jafarabadi M, Vojouhi S. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Complement Ther Med 2020;49:102290. [PMID: 32147076 DOI: 10.1016/j.ctim.2019.102290] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
28 Grasselli E, Canesi L, Portincasa P, Voci A, Vergani L, Demori I. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. Annals of Hepatology 2017;16:707-19. [DOI: 10.5604/01.3001.0010.2713] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
29 Fakhoury-Sayegh N, Younes H, Heraoui GNHA, Sayegh R. Nutritional Profile and Dietary Patterns of Lebanese Non-Alcoholic Fatty Liver Disease Patients: A Case-Control Study. Nutrients 2017;9:E1245. [PMID: 29135945 DOI: 10.3390/nu9111245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
30 Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(17): 3150-3162 [PMID: 28533672 DOI: 10.3748/wjg.v23.i17.3150] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 40] [Article Influence: 12.5] [Reference Citation Analysis]
31 Fan H, Ma X, Lin P, Kang Q, Zhao Z, Wang L, Sun D, Cheng J, Li Y. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats. Med Sci Monit 2017;23:5599-612. [PMID: 29172017 DOI: 10.12659/msm.907530] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
32 Abenavoli L, Di Renzo L, Boccuto L, Alwardat N, Gratteri S, De Lorenzo A. Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2018;12:873-881. [PMID: 30033779 DOI: 10.1080/17474124.2018.1503947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
33 Zeng J, Yang RX, Sun C, Pan Q, Zhang RN, Chen GY, Hu Y, Fan JG. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. World J Gastroenterol 2020; 26(15): 1792-1804 [PMID: 32351294 DOI: 10.3748/wjg.v26.i15.1792] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
34 Abenavoli L, Izzo AA, Milić N, Cicala C, Santini A, Capasso R. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res 2018;32:2202-13. [PMID: 30080294 DOI: 10.1002/ptr.6171] [Cited by in Crossref: 121] [Cited by in F6Publishing: 95] [Article Influence: 40.3] [Reference Citation Analysis]
35 MacLean C, Dillon J, Babraj JA, Vollaard NB. The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease. Phys Sportsmed 2018;46:87-92. [PMID: 29183220 DOI: 10.1080/00913847.2018.1411171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Watzinger C, Nonnenmacher T, Grafetstätter M, Sowah SA, Ulrich CM, Kauczor HU, Kaaks R, Schübel R, Nattenmüller J, Kühn T. Dietary Factors in Relation to Liver Fat Content: A Cross-sectional Study. Nutrients 2020;12:E825. [PMID: 32244908 DOI: 10.3390/nu12030825] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
37 Li P, Fan C, Cai Y, Fang S, Zeng Y, Zhang Y, Lin X, Zhang H, Xue Y, Guan M. Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. Adipocyte 2020;9:57-67. [PMID: 32000567 DOI: 10.1080/21623945.2020.1721970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
38 Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients 2021;13:494. [PMID: 33546130 DOI: 10.3390/nu13020494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
39 Shabalala SC, Dludla PV, Mabasa L, Kappo AP, Basson AK, Pheiffer C, Johnson R. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed Pharmacother 2020;131:110785. [PMID: 33152943 DOI: 10.1016/j.biopha.2020.110785] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
40 Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, Di Renzo L, De Lorenzo A. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. Int J Environ Res Public Health. 2019;16. [PMID: 31438482 DOI: 10.3390/ijerph16173011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
41 Kutlu O, Altun Ö, Dikker O, Aktaş Ş, Özsoy N, Arman Y, Özgün Çil E, Özcan M, Aydın Yoldemir Ş, Akarsu M, Toprak İD, Kırna K, Kutlu Y, Toprak Z, Eruzun H, Tükek T. Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. Med Princ Pract 2019;28:463-9. [PMID: 30995640 DOI: 10.1159/000500106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
42 Lian C, Zhai Z, Li Z, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020;330:109199. [DOI: 10.1016/j.cbi.2020.109199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
43 Khalatbari-Soltani S, Imamura F, Brage S, De Lucia Rolfe E, Griffin SJ, Wareham NJ, Marques-Vidal P, Forouhi NG. The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study. BMC Med 2019;17:19. [PMID: 30674308 DOI: 10.1186/s12916-019-1251-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
44 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. BMC Gastroenterol 2021;21:223. [PMID: 34001028 DOI: 10.1186/s12876-021-01809-2] [Reference Citation Analysis]
45 Koutoukidis DA, Koshiaris C, Henry JA, Noreik M, Morris E, Manoharan I, Tudor K, Bodenham E, Dunnigan A, Jebb SA, Aveyard P. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2021;115:154455. [PMID: 33259835 DOI: 10.1016/j.metabol.2020.154455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
46 Nikkhah-bodaghi M, Ghanavati M, Hekmatdoost A. Polyphenol intakes and risk of impaired lipid profile, elevated hepatic enzymes and nonalcoholic fatty liver disease. NFS 2019;49:903-10. [DOI: 10.1108/nfs-12-2018-0338] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
47 Chen C, Zhu Z, Mao Y, Xu Y, Du J, Tang X, Cao H. HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. Biosci Rep 2020;40:BSR20193996. [PMID: 31940026 DOI: 10.1042/BSR20193996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
48 Hernández-Conde M, Llop E, Fernández Carrillo C, Tormo B, Abad J, Rodriguez L, Perelló C, López Gomez M, Martínez-Porras JL, Fernández Puga N, Trapero-Marugan M, Fraga E, Ferre Aracil C, Calleja Panero JL. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(42): 6658-6668 [PMID: 33268953 DOI: 10.3748/wjg.v26.i42.6658] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Li J, Zhu L, Zhang YM, Chen H, Miao YF, Kang HX, Ren HY, Wan MH, Long D, Tang WF. Sheng-Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in Rats. Evid Based Complement Alternat Med. 2018;2018:6190254. [PMID: 30402130 DOI: 10.1155/2018/6190254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
50 Yoshitaka H, Hamaguchi M, Kojima T, Fukuda T, Ohbora A, Fukui M. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. Medicine (Baltimore). 2017;96:e6712. [PMID: 28471965 DOI: 10.1097/md.0000000000006712] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 9.3] [Reference Citation Analysis]
51 Colica C, Abenavoli L. Resistin Levels in Non-alcoholic Fatty Liver Disease Pathogenesis. J Transl Int Med 2018;6:52-3. [PMID: 29607306 DOI: 10.2478/jtim-2018-0011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
52 Eslamparast T, Tandon P, Raman M. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients. 2017;9. [PMID: 28933748 DOI: 10.3390/nu9080800] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
53 Hormoznejad R, Mohammad Shahi M, Rahim F, Helli B, Alavinejad P, Sharhani A. Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial. Int J Food Sci Nutr 2020;71:991-1000. [PMID: 32237922 DOI: 10.1080/09637486.2020.1746957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Azzaroli F, Mazzella G, Marchesini G, Brodosi L, Petroni ML. Fatty liver in pregnancy: a narrative review of two distinct conditions. Expert Rev Gastroenterol Hepatol 2020;14:127-35. [PMID: 31928239 DOI: 10.1080/17474124.2020.1715210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Ratjen I, Morze J, Enderle J, Both M, Borggrefe J, Müller HP, Kassubek J, Koch M, Lieb W. Adherence to a plant-based diet in relation to adipose tissue volumes and liver fat content. Am J Clin Nutr 2020;112:354-63. [PMID: 32453423 DOI: 10.1093/ajcn/nqaa119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
56 Chen CX, Mao YS, Foster P, Zhu ZW, Du J, Guo CY. Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease. Appl Physiol Nutr Metab 2017;42:295-301. [PMID: 28177748 DOI: 10.1139/apnm-2016-0499] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
57 Miya A, Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T. Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. J Diabetes Investig 2020;11:964-70. [PMID: 31999890 DOI: 10.1111/jdi.13221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wei YT, Lee PY, Lin CY, Chen HJ, Lin CC, Wu JS, Chang YF, Wu CL, Guo HR. Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan. BMC Gastroenterol 2020;20:32. [PMID: 32041532 DOI: 10.1186/s12876-020-1178-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Recena Aydos L, Aparecida do Amaral L, Serafim de Souza R, Jacobowski AC, Freitas Dos Santos E, Rodrigues Macedo ML. Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. Nutrients 2019;11:E3067. [PMID: 31888190 DOI: 10.3390/nu11123067] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
60 Nass KJ, van den Berg EH, Faber KN, Schreuder TC, Blokzijl H, Dullaart RP. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study. Metabolism 2017;72:37-46. [DOI: 10.1016/j.metabol.2017.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
61 Zhang S, Du T, Li M, Lu H, Lin X, Yu X. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. Medicine (Baltimore) 2017;96:e6381. [PMID: 28328829 DOI: 10.1097/MD.0000000000006381] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
62 Sabrina N, Bai CH, Chang CC, Chien YW, Chen JR, Chang JS. Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women. Nutrients. 2017;9. [PMID: 28777296 DOI: 10.3390/nu9080833] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
63 Klisic A, Abenavoli L, Fagoonee S, Kavaric N, Kocic G, Ninić A. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. Minerva Med 2019;110:191-8. [PMID: 30784251 DOI: 10.23736/S0026-4806.19.05978-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
64 Abenavoli L, Falalyeyeva T, Boccuto L, Tsyryuk O, Kobyliak N. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease. Pharmaceuticals (Basel) 2018;11:E104. [PMID: 30314377 DOI: 10.3390/ph11040104] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
65 Jang EH, Chang Y, Ryu S, Kim S, Kim YH, Sung KC, Cho YK, Lee SJ, Shin H, Wild SH, Byrne CD. Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study. J Clin Med 2019;8:E610. [PMID: 31064105 DOI: 10.3390/jcm8050610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Suárez M, Boqué N, Del Bas JM, Mayneris-Perxachs J, Arola L, Caimari A. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017;9:E1052. [PMID: 28937599 DOI: 10.3390/nu9101052] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
67 Sumida Y, Yoneda M, Ogawa Y, Yoneda M, Okanoue T, Nakajima A. Current and new pharmacotherapy options for non-alcoholic steatohepatitis. Expert Opin Pharmacother 2020;21:953-67. [PMID: 32237916 DOI: 10.1080/14656566.2020.1744564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
68 Perrone MA, Gualtieri P, Gratteri S, Ali W, Sergi D, Muscoli S, Cammarano A, Bernardini S, Di Renzo L, Romeo F. Effects of postprandial hydroxytyrosol and derivates on oxidation of LDL, cardiometabolic state and gene expression: a nutrigenomic approach for cardiovascular prevention. J Cardiovasc Med (Hagerstown) 2019;20:419-26. [PMID: 31593559 DOI: 10.2459/JCM.0000000000000816] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
69 Elseweidy MM, Ali SI, Shershir NI, Ali AEA, Hammad SK. Vitamin D3 intake as modulator for the early biomarkers of myocardial tissue injury in diabetic hyperlipidaemic rats. Arch Physiol Biochem 2020;:1-9. [PMID: 32046509 DOI: 10.1080/13813455.2020.1716015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Golabi P, Stepanova M, Pham HT, Cable R, Rafiq N, Bush H, Gogoll T, Younossi ZM. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterol 2018;5:e000198. [PMID: 29607054 DOI: 10.1136/bmjgast-2018-000198] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
71 Mayr HL, Kelly JT, Macdonald GA, Hickman IJ. 'Focus on diet quality': a qualitative study of clinicians' perspectives of use of the Mediterranean dietary pattern for non-alcoholic fatty liver disease. Br J Nutr 2021;:1-11. [PMID: 33766176 DOI: 10.1017/S0007114521001100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Abenavoli L, Milic N, Luzza F, Boccuto L, De Lorenzo A. Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease. J Transl Int Med. 2017;5:144-147. [PMID: 29164049 DOI: 10.1515/jtim-2017-0027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
73 Ebert T, Linder N, Schaudinn A, Busse H, Berger J, Lichtinghagen R, Keim V, Wiegand J, Karlas T. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease. Endocrine 2017;58:246-52. [DOI: 10.1007/s12020-017-1417-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
74 Milošević N, Milanović M, Sudji J, Bosić Živanović D, Stojanoski S, Vuković B, Milić N, Medić Stojanoska M. Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans? Environ Sci Pollut Res Int 2020;27:772-84. [PMID: 31808097 DOI: 10.1007/s11356-019-06831-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
75 Cao X, Gu Y, Bian S, Zhang Q, Meng G, Liu L, Wu H, Zhang S, Wang Y, Zhang T, Wang X, Sun S, Wang X, Jia Q, Song K, Niu K. Association between eating speed and newly diagnosed nonalcoholic fatty liver disease among the general population. Nutr Res 2020;80:78-88. [PMID: 32736293 DOI: 10.1016/j.nutres.2020.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
76 Chen YJ, Chen JT, Tai MC, Liang CM, Chen YY, Kao TW, Fang WH, Chen WL. Examining the associations among intraocular pressure, hepatic steatosis, and anthropometric parameters. Medicine (Baltimore) 2019;98:e17598. [PMID: 31651867 DOI: 10.1097/MD.0000000000017598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Zhang M, Lin S, Wang MF, Huang JF, Liu SY, Wu SM, Zhang HY, Wu ZM, Liu WY, Zhang DC, Hao CM, Zhu YY, Zheng MH, Wang XZ. Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west? BMC Gastroenterol 2020;20:139. [PMID: 32375660 DOI: 10.1186/s12876-020-01278-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
78 Khalatbari-Soltani S, Marques-Vidal P, Imamura F, Forouhi NG. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study. BMJ Open 2020;10:e040959. [PMID: 33371031 DOI: 10.1136/bmjopen-2020-040959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Hashimoto Y, Hamaguchi M, Fukuda T, Ohbora A, Kojima T, Fukui M. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 2017;57:89-97. [DOI: 10.1007/s12020-017-1313-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
80 Jeong YH, Hur HJ, Jeon EJ, Park SJ, Hwang JT, Lee AS, Lee KW, Sung MJ. Honokiol Improves Liver Steatosis in Ovariectomized Mice. Molecules 2018;23:E194. [PMID: 29342107 DOI: 10.3390/molecules23010194] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
81 Nivukoski U, Niemelä M, Bloigu A, Bloigu R, Aalto M, Laatikainen T, Niemelä O. Combined effects of lifestyle risk factors on fatty liver index. BMC Gastroenterol 2020;20:109. [PMID: 32293287 DOI: 10.1186/s12876-020-01270-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 García-compeán D, Villarreal-pérez JZ, Cavazos MEDLO, Lavalle-gonzalez FJ, Borjas-almaguer OD, Del Cueto-aguilera AN, González-gonzález JA, Treviño-garza C, Huerta-pérez L, Maldonado-garza HJ. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Annals of Hepatology 2020;19:258-64. [DOI: 10.1016/j.aohep.2020.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Belemets N, Kobyliak N, Falalyeyeva T, Kuryk O, Sulaieva O, Vovk T, Beregova T, Ostapchenko L. Polyphenol Compounds Melanin Prevented Hepatic Inflammation in Rats with Experimental Obesity. Natural Product Communications 2018;13:1934578X1801301. [DOI: 10.1177/1934578x1801301118] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Al Zarzour RH, Ahmad M, Asmawi MZ, Kaur G, Saeed MAA, Al-Mansoub MA, Saghir SAM, Usman NS, Al-Dulaimi DW, Yam MF. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats. Nutrients. 2017;9:776. [PMID: 28718838 DOI: 10.3390/nu9070766] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
85 Hegazy M, Elsayed NM, Ali HM, Hassan HG, Rashed L. Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link? J Diabetes Res 2019;2019:5267025. [PMID: 31089474 DOI: 10.1155/2019/5267025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
86 Ristic-Medic D, Kovacic M, Takic M, Arsic A, Petrovic S, Paunovic M, Jovicic M, Vucic V. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.Nutrients. 2020;13:15. [PMID: 33374554 DOI: 10.3390/nu13010015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
87 Abdallah MS, Eldeen AH, Tantawy SS, Mostafa TM. The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. Eur J Pharmacol 2021;906:174295. [PMID: 34214585 DOI: 10.1016/j.ejphar.2021.174295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Koutoukidis DA, Jebb SA, Aveyard P, Astbury NM. The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial. Obes Facts 2020;13:144-51. [PMID: 32200381 DOI: 10.1159/000505667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Lin S, Xian Y, Liu Y, Cai W, Song J, Zhang X. Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China. Medicine (Baltimore) 2018;97:e0021. [PMID: 29489647 DOI: 10.1097/MD.0000000000010021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
90 Zou W, Zhang C, Gu X, Li X, Zhu H. Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats. Drug Des Devel Ther 2021;15:2565-76. [PMID: 34168429 DOI: 10.2147/DDDT.S307257] [Reference Citation Analysis]
91 Wen F, Shi Z, Liu X, Tan Y, Wei L, Zhu X, Zhang H, Zhu X, Meng X, Ji W, Yang M, Lu Z. Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice. Horm Metab Res 2021;53:132-44. [PMID: 33302316 DOI: 10.1055/a-1293-8250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, Luzza F. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. Nutrients 2017;9:E870. [PMID: 28805669 DOI: 10.3390/nu9080870] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
93 Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, Aiello V, Romano B, De Lorenzo A, Izzo AA, Capasso R. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients. 2019;11:2690. [PMID: 31703257 DOI: 10.3390/nu11112690] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 37.5] [Reference Citation Analysis]
94 Bosch DE, Yeh MM. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease. Hum Pathol 2017;69:55-62. [PMID: 28970141 DOI: 10.1016/j.humpath.2017.09.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]